Tag: EpCAM

Methods METEOR is really a randomized placebo-controlle

\n\nMethods.METEOR can be a randomized placebo-controlled demo which assessed the result involving Forty five milligram involving rosuvastatin on 2-year difference in carotid intima press thickness (CIMT) amongst 984 low-risk people (10-year Framingham risk < 10%) using humble CIMT (CIMT >= One.Only two along with < Several.Five millimeter) as well as…

Continue Reading Methods METEOR is really a randomized placebo-controlle

Differences in Germline Variant Spectrum Between Black and White Men With Prostate Cancer

By Matthew StengerPosted: 6/13/2022 10:50:00 AM Last Updated: 6/13/2022 10:00:21 AM In a study presented at the 2022 ASCO Annual Meeting (Abstract 10502) and simultaneously published in JCO Precision Oncology, Veda N. Giri, MD, and colleagues found that Black men with prostate cancer exhibited a lower frequency and narrower spectrum…

Continue Reading Differences in Germline Variant Spectrum Between Black and White Men With Prostate Cancer

Researchers use nanotechnology to destroy and prevent relapse of solid tumor cancers

Generation and characterization of DCNV-rAd-Ag. a, Generation of DCNVs derived from adenovirus-infected mature dendritic cells. (1) The genes of tumor-specific antigen were genetically engineered into the adenovirus vector. (2) Recombinant adenovirus infected the immature DC2.4 cells to express the modified antigen on the cell surface and stimulate it. (3) Differentiation,…

Continue Reading Researchers use nanotechnology to destroy and prevent relapse of solid tumor cancers

EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab – Yu

The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader). Alternatively, you can also download the PDF file directly to your computer, from where it can be opened using a PDF reader. To…

Continue Reading EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab – Yu

LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting

GUANGZHOU, China–(BUSINESS WIRE)–LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting….

Continue Reading LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting

Figure 3 | Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma including TECs

Single sorted bone marrow-derived CD45+ EpCAM+ cells express both the CD45 and EpCAM genes and surface proteins. CD45+ EpCAM+ cells were sorted to high purity and analyzed for CD45 and EpCAM expression using immunofluorescence microscopy, as well as qRT-PCR. CD45+ EpCAM- cells were also sorted as a control. (a) FACS…

Continue Reading Figure 3 | Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma including TECs

EpCAM antibody [G8.8] | Axil Scientific

This website uses cookies to ensure the best experience. By continuing, you agree to our privacy policy. × Product successfully added to quote! × There are items in your quote. Brand: Reference GTX80323 Brand GeneTex Application FACSICC/IFIHC-FrIPWB Storage Conditions Store as concentrated solution. Centrifuge briefly prior to opening vial. For…

Continue Reading EpCAM antibody [G8.8] | Axil Scientific

N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance | Military Medical Research

Bioinformatics analyses revealed the involvement of m6A modification in cervical cancer progression To better understand whether and how m6A regulators contribute to cervical cancer progression, we first identified 9 m6A writers (WTAP, ZC3H13, METTL3, METTL14, METTL16, VIRMA, RBM15B, RBM15, and CBLL1), 15 m6A readers (FMR1, hnRNPA2B1, hnRNPC, YTHDF1/2/3, YTHDC1/2, LRPPRC,…

Continue Reading N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance | Military Medical Research

EpCAM Is Essential to Maintaining the Immune Homeostasis of Intestines via Keeping the Expression of pIgR in the Intestinal Epithelium of Mice

EpCAM deficiency causes congenital tufting enteropathy (CTE) which is considered as one kinds of very early onset inflammatory bowel disease (IBD). However, functions of EpCAM on regulating the immunity of intestines are still unclear. To study the mechanism of EpCAM on maintaining the intestinal immune homeostasis, the intestines of WT…

Continue Reading EpCAM Is Essential to Maintaining the Immune Homeostasis of Intestines via Keeping the Expression of pIgR in the Intestinal Epithelium of Mice

Development of A Novel Anti-Epcam Monoclonal Antibody for Various Applications[v1]

Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed Version 1 : Received: 28 March 2022 / Approved: 28 March 2022 / Online: 28 March 2022 (10:11:34 CEST) Li, G.; Suzuki, H.; Asano, T.; Tanaka, T.; Suzuki, H.; Kaneko, M.K.; Kato, Y. Development of A Novel Anti-Epcam…

Continue Reading Development of A Novel Anti-Epcam Monoclonal Antibody for Various Applications[v1]

Affimed Announces Publication of Preclinical Data Demonstrating Cytotoxic Potency and Efficacy of NK Cells Precomplexed with Innate Cell Engagers after Freezing & Thawing

Precomplexing NK cells with Innate Cell Engagers (ICE® molecules) results in a CAR-like NK cell product, whose magnitude and specificity of antibody-dependent cellular cytotoxicity (ADCC) remain unaffected after one freeze-thaw cycle HEIDELBERG, Germany, Feb. 09, 2022 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving…

Continue Reading Affimed Announces Publication of Preclinical Data Demonstrating Cytotoxic Potency and Efficacy of NK Cells Precomplexed with Innate Cell Engagers after Freezing & Thawing

Sesen Bio (SESN) falls 5.75% on Moderate Volume February 2

Last Price $ Last Trade Change $ Change Percent % Open $ Prev Close $ High $ low $ 52 Week High $ 52 Week Low $ Market Cap PE Ratio Volume Exchange SESN – Market Data & News Trade Today, Sesen Bio Inc. Inc’s (NASDAQ: SESN) stock fell…

Continue Reading Sesen Bio (SESN) falls 5.75% on Moderate Volume February 2

EPCAM – PrimePCR Assay and Template | Life Science

Control assays and synthetic DNA templates were designed to facilitate the assessment of the key experimental factors impacting your real-time PCR results. DNA Contamination Control AssayUse the PrimePCR DNA contamination control assay to determine if genomic DNA (gDNA) is present in a sample at a level that may affect PCR…

Continue Reading EPCAM – PrimePCR Assay and Template | Life Science

Human EpCAM/TROP1 (NP_002345) VersaClone cDNA RDC1470: R&D Systems

Long Name Epithelial Cell Adhesion Molecule Entrez Gene IDs 4072 (Human); 17075 (Mouse); 171577 (Rat); 102123042 (Cynomolgus Monkey) Alternate Names 17-1A; 323/A3; ACSTD1; antigen identified by monoclonal AUA1; CD326 antigen; CD326; Cell surface glycoprotein Trop-1; chromosome 4, surface marker (35kD glycoprotein); DIAR5; EGP; EGP-2; EGP314; EGP40; EpCAM; epithelial cell adhesion…

Continue Reading Human EpCAM/TROP1 (NP_002345) VersaClone cDNA RDC1470: R&D Systems

Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer b

Introduction Prostate cancer (PCa) is one of the most common genitourinary system malignant tumor in men worldwide. In Asian countries, many patients with PCa are often diagnosed at an advanced stage maybe mostly because of a large population base with relatively backward economic development and imperfect cancer screening system of…

Continue Reading Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer b